Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury
NCT04511923
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Covid19
ARDS, Human
Lung Injury, Acute
Ventilation Perfusion Mismatch
Interventions
DRUG:
Nebulised heparin
Sponsor
University College Hospital Galway